Status of work in March
In March, AOTMiT begins work on orders from the Minister of Health:
- Jaypirca (pirtobrutinib) for the treatment of patients with B-cell lymphomas
- Jaypirca (pirtobrutinib) for the treatment of patients with chronic lymphocytic leukemia
- Ramizek Plus (ramiprilum + bisoprololi fumaras) for the treatment of replacement chronic coronary syndrome (after myocardial infarction or revascularization) or chronic heart failure with reduced left ventricular systolic function in adult patients
- Vaxigrip, trivalent influenza vaccine
The listed order is available on the AOTMiT Public Information Bulletin.